{"title":"Correction to: RBX2660 (REBYOTA^®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA","authors":"Hannah A. Blair","doi":"10.1007/s40267-023-01035-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11371,"journal":{"name":"Drugs & Therapy Perspectives","volume":"54 ","pages":"447"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Therapy Perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40267-023-01035-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}